TSE:ONC

Oncolytics Biotech (ONC) Stock Price, News & Analysis

Oncolytics Biotech logo
C$14.90 -0.20 (-1.32%)
As of 09/3/2025

About Oncolytics Biotech Stock (TSE:ONC)

Key Stats

Today's Range
C$14.90
▼
C$14.90
50-Day Range
C$14.90
▼
C$14.90
52-Week Range
C$0.44
▼
C$2.08
Volume
280 shs
Average Volume
169,589 shs
Market Capitalization
C$1.50 billion
P/E Ratio
N/A
Dividend Yield
0.31%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Oncolytics Biotech Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. The company is developing pelareorep, an intravenously delivered immunotherapeutic agent, which is in phase 3 clinical trial for the treatment of hormone receptor-positive / human epidermal growth factor 2-negative metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma. It has a co-development agreement with Merck KGaA and Pfizer Inc. to co-develop pelareorep, as well as with Roche Holding AG. The company was incorporated in 1998 and is headquartered in Calgary, Canada.

Receive ONC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Oncolytics Biotech and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ONC Stock News Headlines

This Could Be the Biggest Monetary Shift in 50 Years
The U.S. government still values its gold reserves at $42 an ounce, a price set by Congress in 1973. Gold trades above $4,000 today. That gap means Washington's books show about $11 billion in gold that is actually worth more than $1 trillion. A bill in Congress would require repricing those reserves at market value. More than 60 million Americans qualify to move part of their savings into physical gold, tax-free and penalty-free, according to the 2026 Gold and Silver Guide.tc pixel
See More Headlines

ONC Stock Analysis - Frequently Asked Questions

Oncolytics Biotech's stock was trading at C$14.90 at the beginning of 2026. Since then, ONC stock has increased by 0.0% and is now trading at C$14.90.

Oncolytics Biotech Inc. (TSE:ONC) announced its quarterly earnings data on Tuesday, November, 12th. The company reported C($0.12) earnings per share for the quarter, missing the consensus estimate of C($0.11) by C$0.01.

Based on aggregate information from My MarketBeat watchlists, some other companies that Oncolytics Biotech investors own include Oncolytics Biotech (ONCY), Sorrento Therapeutics (SRNE), Enbridge (ENB), Organigram (OGI), ProMetic Life Sciences (PLI), Air Canada (AC) and BlackBerry (BB).

Industry, Sector and Symbol

Stock Exchange
TSE
Industry
Biotechnology
Sub-Industry
Biotechnology
Current Symbol
TSE:ONC
CIK
N/A
Fax
N/A
Employees
29
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
C($0.37)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-C$27.66 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-189.05%
Return on Assets
-71.33%

Debt

Debt-to-Equity Ratio
17.78
Current Ratio
2.82
Quick Ratio
8.86

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
C$3.53 per share
Price / Cash Flow
4.22
Book Value
C$0.08 per share
Price / Book
190.47

Miscellaneous

Outstanding Shares
100,361,000
Free Float
N/A
Market Cap
C$1.50 billion
Optionable
Not Optionable
Beta
0.80
Don't Wait for the OpenAI IPO Cover

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report

This page (TSE:ONC) was last updated on 9/3/2025 by MarketBeat.com Staff.
From Our Partners